KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Johnson & Johnson (JNJ) Long-Term Deferred Tax (2016 - 2025)

Johnson & Johnson (JNJ) has disclosed Long-Term Deferred Tax for 17 consecutive years, with $6.9 billion as the latest value for Q4 2025.

  • Quarterly Long-Term Deferred Tax fell 34.29% to $6.9 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $6.9 billion through Dec 2025, down 34.29% year-over-year, with the annual reading at $6.9 billion for FY2025, 34.29% down from the prior year.
  • Long-Term Deferred Tax hit $6.9 billion in Q4 2025 for Johnson & Johnson, up from $6.7 billion in the prior quarter.
  • In the past five years, Long-Term Deferred Tax ranged from a high of $10.8 billion in Q3 2021 to a low of $6.7 billion in Q3 2025.
  • Historically, Long-Term Deferred Tax has averaged $9.1 billion across 5 years, with a median of $9.3 billion in 2023.
  • Biggest five-year swings in Long-Term Deferred Tax: soared 38.42% in 2021 and later plummeted 34.29% in 2025.
  • Year by year, Long-Term Deferred Tax stood at $10.6 billion in 2021, then fell by 11.78% to $9.4 billion in 2022, then dropped by 1.2% to $9.3 billion in 2023, then grew by 12.74% to $10.5 billion in 2024, then tumbled by 34.29% to $6.9 billion in 2025.
  • Business Quant data shows Long-Term Deferred Tax for JNJ at $6.9 billion in Q4 2025, $6.7 billion in Q3 2025, and $6.8 billion in Q2 2025.